Navigation Links
Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
Date:5/6/2008

ROCKVILLE, Md., May 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2008 first quarter financial results in a press release to be issued after 8:00 a.m. Eastern Time on May 9, 2008. The Company will hold an investor conference call to discuss its financial results at 10:00 a.m. Eastern Time on May 9, 2008. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management. A question and answer session will follow the financial results overview. The dial-in number for the conference call is USA and Canada (866) 793 1299 International: (703) 639 1306.

A live audio webcast of the conference call will be available at http://www.novavax.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available for 90 days after the webcast and a replay of the conference call will also be available by telephone beginning 1pm EDT. May 9, 2007 through midnight May 16, 2008. To access the replay, dial (888) 266 2081 and enter pass code 1225974.

About Novavax, Inc.

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, highly potent, recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...dBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--Do...ssetsofHylandSeeds,adivisionofThompsonsLimitedofBl...expandDowAgroSciences,currentseedsbusinessasthecom... 2010 andDowAgroSciencesHerbicideTolerantTraitTec...dinthenearfuture. ,, "Thisacquisitionbringstoge...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.ann...wedthepatentapplicationfor,itsnano-particleoraldel...yefficientapproachtoincorporatepeptidesor,proteins...ofdrugs,otherwiseadministeredasinjections.NODtechn...acromoleculardrugssuchasinsulin,interferon,growth...
(Date:11/24/2009)...ficacyendpointhasbeenmetforpatientswithadvanced-st...Y,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc....armaceuticalcompanyfocusedonendocrinetherapyandonc...2studywithitstargetedcytotoxicpeptideconjugate,AEZ...rrentendometrialcancer.Inapersonalizedhealthcareap...
(Date:11/24/2009)...ly,November24/PRNewswire/--HealthRoboticstodayanno...groupofselected,investors.ThisrecentlyformedToront...csCanada,Inc.andwillmarket,install,andsupport,Heal...sthe,revolutionaryproductofferingsi.v.STATION(TM),...illalsoprovideassistanceonan"asneeded,basis"toitss...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...1 NanoLogix, Inc. (Pink Sheets: NNLX) is pleased ...oard to help evaluate and target research and deve...ard provides the company with a vastly expanded sc...esearch. , , Dr. Robert Ollar, NanoLogix cofound...esigned from the NanoLogix Board of Directors to a...
...d LONDON, May 11 Nanosys Inc. and QuantuMDx Group ...exclusive license agreement with Nanosys for sever...use of nanowires for biosensors. , , The core i...based field effect transistors (FETs) as biosensor... Lieber, a professor of chemistry at Harvard , a ...
...rexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a...t of obesity, today announced that Jay Hagan has j... Corporate Development and Strategy. , , "Jay b... business development experience in a variety of r...of important transactions. We are excited to add ...
Other Biology Technology:A Global View: NanoLogix Creates Science Advisory Board 2A Global View: NanoLogix Creates Science Advisory Board 3A Global View: NanoLogix Creates Science Advisory Board 4A Global View: NanoLogix Creates Science Advisory Board 5Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies 2Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic and Sequencing Technologies 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 2Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 3Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy 4
(Date:11/24/2009)...Rocket science is opening new doors to understandi...ect the hearing of a marine mammal or if they hea... sized X-ray scanners that NASA uses to detect fla...ets is now allowing scientists to peek inside the ...ailed three-dimensional replicas of a whale,s hear...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- Th...day a report revealing that the last remaining pop...nificantly due to the rising tide of poaching and ...will help inform Russian officials of what needs t...world,s biggest cat. , The report w...
(Date:11/23/2009)...CINCINNATINew research presents strong evidence th... to both outdoor traffic-related pollution and ind... than one or the other exposure alone. , Envir...ncinnati (UC) College of Medicine have shown that ...lated particles and indoor endotoxin during early ...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2
...ew Haven, Conn. David Spiegel , assistant profes... $1.5 million National Institutes of Health (NIH) ...s work designing a rational approach for using ant...ase types. , The New Innovator Awards are reserv...re just beginning their careers and have not yet r...
...adrid, Spain - Spanish authorities have announced ...on of Iberian lynx, triggering hope for one of the...ldlife Fund today. , We are excited and amazed by...ecies Program in Spain. However, we are a long way...tion. , It appears that the new population was di...
...AST LANSING, Mich. The computer program Captains L...h attention deficit hyperactivity disorder, brain ...d to rehabilitate Ugandan children who are survivo...gan State University associate professor of neurol... Giordani, a University of Michigan associate prof...
Other Biology News:Yale chemist receives NIH Young Investigator Award for antibody targeting 2Yale chemist receives NIH Young Investigator Award for antibody targeting 3MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria 2
DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
... E. coli containing a clone of the human Topoisome...ters the topological state of nucleic acids by pas... which generates a separate DNA helix (1,2) . As a...sm, the enzyme can relax negatively or positively ...
...ease-free Klenow Fragment is a genetically enginee...ase activity has been removed, leaving only the 5 ...clease activity makes Exo- Klenow Fragment the enz...NA probes by the random primed method, and for DNA...
Klenow Enzyme; labeling grade, DNA Polymerase I, large fragment from Roche Applied Science
Biology Products: